HC
SANA icon

Hurley Capital’s Sana Biotechnology SANA Stock Holding History

Hurley Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98K Hold
2,000
– – ﹤0.01% 373
2026
Q1 		$5.76K Hold
2,000
– – ﹤0.01% 402
2025
Q4 		$8.14K Hold
2,000
– – ﹤0.01% 355
2025
Q3 		$7.1K Buy
+2,000
New +$7.23K ﹤0.01% 403

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Hurley Capital's SANA Position: Q2 2026 in Review

Hurley Capital held its Sana Biotechnology (SANA) position steady in Q2 2026 at 2,000 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #373.

Hurley Capital first reported a position in SANA in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.14K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Hurley Capital held 2,000 shares of Sana Biotechnology worth $6.98K as of Q2 2026.
  • Hurley Capital left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Hurley Capital's portfolio in Q2 2026, its #373 holding.
  • Hurley Capital first reported a position in Sana Biotechnology in Q3 2025 and has held it in 4 quarters since.
  • Hurley Capital's Sana Biotechnology position peaked at $8.14K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.